Atlas Trials

Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers

Clinical trial NCT00343044 · COMPLETED

Trial details

NCT number
NCT00343044
Sponsor
Benaroya Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Start date
2006-06-01
Primary completion
2010-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.